Interactions among SR Proteins, an Exonic Splicing Enhancer, and a Lentivirus Rev Protein Regulate Alternative Splicing

REFERENCES

• Amendt, B., D. Hesslein, L. J. Chang, and C. M. Stoltzfus. 1994. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 14:3960–3970.
   PubMedGoogle Scholar
• Amendt, B. A., Z.-H. Si, and C. M. Stoltzfus. 1995. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat/rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell. Biol. 15:4606–4615.
   PubMedGoogle Scholar
• Bray, M., S. Prasad, J. W. Dubay, E. Hunter, K.-T. Jeang, D. Rekosh, and M.-L. Hammarskjold. 1994. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA 91:1256–1260.
   PubMed Web of Science ®Google Scholar
• Caceres, J. F., S. Stamm, D. M. Helfman, and A. R. Krainer. 1994. Regulation of alternative splicing by overexpression of antagonistic splicing factors. Science 265:1706–1709.
   PubMed Web of Science ®Google Scholar
• Caputi, M., G. Casari, S. Guenz, R. Tagliabue, A. Sidoli, C. A. Melo, and F. E. Baralle. 1994. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res. 22:1018–1022.
   PubMedGoogle Scholar
• Chang, D. D., and P. A. Sharp. 1989. Regulation by HIV rev depends upon recognition of splice sites. Cell 59:789–795.
   PubMedGoogle Scholar
• Cullen, B. R. 1992. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:375–394.
   PubMedGoogle Scholar
• Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387–395.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Eperon, I. C., D. C. Ireland, R. A. Smith, A. Mayeda, and A. R. Krainer. 1993. Pathways for selection of 5′ splice sites by U1 snRNPs and SF2/ASF. 1993. EMBO J. 12:3607–3617.
   PubMedGoogle Scholar
• Fu, X.-D. 1995. The superfamily of arginine-serine-rich splicing factors. RNA 1:663–680.
   PubMed Web of Science ®Google Scholar
• Fu, X.-D., R. A. Katz, A. M. Skalka, and T. Maniatis. 1991. The role of branchpoint and 3′ exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes Dev. 5:211–220.
   PubMedGoogle Scholar
• Fu, X.-D., and T. Maniatis. 1992. The 35 kDa mammalian splicing factor SC35 mediates specific interactions between U1 and U2 small nuclear ribo-nucleoprotein particles at the 3′ splice site. Proc. Natl. Acad. Sci. USA 89:1725–1729.
   PubMedGoogle Scholar
• Fu, X.-D., T. Maniatis, and A. R. Krainer. 1992. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5′ and 3′ splice site selection. Proc. Natl. Acad. Sci. USA 89:11224–11228.
   PubMed Web of Science ®Google Scholar
• Ge, H., and J. L. Manley. 1990. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell 62:25–34.
   PubMed Web of Science ®Google Scholar
• Gontarek, R. R., M. T. McNally, and K. Beemon. 1993. Mutation of an RSV intronic element abolishes both U11/U12 snRNP binding and negative regulation of splicing. Genes Dev. 7:1926–1936.
   PubMedGoogle Scholar
• Gontarek, R. R., and D. Derse. Unpublished data.
   Google Scholar
• Harris, M. et al. Unpublished data.
   Google Scholar
• Horowitz, D. S., and A. R. Krainer. 1994. Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet. 10:100–106.
   PubMedGoogle Scholar
• Humphrey, M. B., J. Bryan, T. A. Cooper, and S. M. Berget. 1995. A 32-nucleotide exon splicing enhancer regulates usage of competing 5′ splice sites in a differential internal exon. Mol. Cell. Biol. 15:3979–3988.
   PubMedGoogle Scholar
• Kjems, J., A. D. Frankel, and P. A. Sharp. 1991. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 rev. Cell 67:169–178.
   PubMed Web of Science ®Google Scholar
• Kjems, J., and P. A. Sharp. 1993. The basic domain of rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6/U5 small nuclear ribonucleoprotein in spliceosome assembly. J. Virol. 67:4769–4776.
   PubMedGoogle Scholar
• Kohtz, J. D., S. F. Jamison, C. L. Will, P. Zuo, R. Luhrmann, M. A. Garcia-Blanco, and J. L. Manley. 1994. Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature (London) 368:119–124.
   PubMed Web of Science ®Google Scholar
• Krainer, A. R., A. Mayeda, D. Kozak, and G. Binns. 1991. Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70k, and Drosophila splicing regulators. Cell 66:383–394.
   PubMed Web of Science ®Google Scholar
• Lavigueur, A., H. La Branche, A. R. Kornblihtt, and B. Chabot. 1993. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 7:2405–2417.
   PubMed Web of Science ®Google Scholar
• Lu, X., J. Heimer, D. Rekosh, and M.-L. Hammarskjold. 1990. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc. Natl. Acad. Sci. USA 87:7598–7602.
   PubMedGoogle Scholar
• Mardon, H. J., G. Sebastio, and F. E. Baralle. 1987. A role for exon sequences in alternative splicing of the human fibronectin gene. Nucleic Acids Res. 15:7725–7733.
   PubMedGoogle Scholar
• Martarano, L., R. Stephens, N. Rice, and D. Derse. 1994. Equine infectious anemia virus trans-regulatory protein rev controls viral mRNA stability, accumulation, and alternative splicing. J. Virol. 68:3102–3111.
   PubMedGoogle Scholar
• Mayeda, A., D. M. Helfman, and A. R. Krainer. 1993. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol. Cell. Biol. 13:2993–3001.
   PubMed Web of Science ®Google Scholar
• Mayeda, A., and A. R. Krainer. 1992. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 68:365–375.
   PubMed Web of Science ®Google Scholar
• McNally, M. T., and K. Beemon. 1992. Intronic sequences and 3′ splice sites control Rous sarcoma virus RNA splicing. J. Virol. 66:6–11.
   PubMedGoogle Scholar
• McNally, M. T., R. R. Gontarek, and K. Beemon. 1991. Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing. Virology 185:99–108.
   PubMedGoogle Scholar
• Melton, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035–7056.
   PubMed Web of Science ®Google Scholar
• Moore, M. J., C. C. Query, and P. A. Sharp. 1993. Splicing of precursors to mRNA by the spliceosome, p. 303–357. In R. F. Gesteland and J. F. Atkins (ed.), The RNA world. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
   Google Scholar
• Nelson, K. K., and M. R. Green. 1990. Mechanism of cryptic splice site activation during pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 87:6253–6257.
   PubMedGoogle Scholar
• Oshima, Y., and Y. Gotoh. 1987. Signals for the selection of a splice site in pre-mRNA. J. Mol. Biol. 195:247–259.
   PubMedGoogle Scholar
• Ramchatesingh, J., A. M. Zahler, K. M. Neugebauer, M. B. Roth, and T. A. Cooper. 1995. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol. Cell. Biol. 15:4898–4907.
   PubMed Web of Science ®Google Scholar
• Roth, M. B., A. M. Zahler, and J. A. Stolk. 1991. A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription. J. Cell Biol. 115:587–596.
   PubMed Web of Science ®Google Scholar
• Smith, C. W. J., J. G. Patton, and B. Nadal-Ginard. 1989. Alternative splicing in the control of gene expression. Annu. Rev. Genet. 23:527–577.
   PubMed Web of Science ®Google Scholar
• Staffa, A., and A. Cochrane. 1994. The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3′ splice site. J. Virol. 68:3071–3079.
   PubMedGoogle Scholar
• Staffa, A., and A. Cochrane. 1995. Identification of positive and negative splicing regulatory elements within the terminal tat/rev exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 15:4597–4605.
   PubMedGoogle Scholar
• Staknis, D., and R. Reed. 1994. SR proteins promote the first specific recognition of pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol. Cell. Biol. 14:7670–7682.
   PubMed Web of Science ®Google Scholar
• Stephens, R. M., D. Derse, and N. R. Rice. 1990. Cloning and characterization of cDNAs encoding equine infectious anemia virus Tat and putative Rev proteins. J. Virol. 64:3716–3725.
   PubMedGoogle Scholar
• Stephens, R. M., and T. D. Schneider. 1992. Features of spliceosome evolution and function inferred from an analysis of the information at human splice sites. J. Mol. Biol. 228:1124–1136.
   PubMedGoogle Scholar
• Stoltzfus, C. M., and S. J. Fogarty. 1989. Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA. J. Virol. 63:1669–1676.
   PubMed Web of Science ®Google Scholar
• Sun, Q., R. K. Hampson, and F. M. Rottman. 1993. In vitro analysis of bovine growth hormone pre-mRNA alternative splicing. Involvement of exon sequences and trans-acting factors. J. Biol. Chem. 268:15659–15666.
   PubMedGoogle Scholar
• Sun, Q., A. Mayeda, R. K. Hampson, A. R. Krainer, and F. M. Rottman. 1993. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 7:2598–2608.
   PubMed Web of Science ®Google Scholar
• Tanaka, K. A., A. Watakabe, and Y. Shimura. 1994. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol. 4:1347–1354.
   Google Scholar
• Tian, M., and T. Maniatis. 1993. A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA. Cell 74:105–114.
   PubMedGoogle Scholar
• van Oers, C. C. M., J. Adema, H. Zandberg, T. C. Moen, and P. D. Bass. 1994. Two different sequence elements within exon 4 are necessary for calcitonin-specific splicing of the human calcitonin/calcitonin gene-related peptide I pre-mRNA. Mol. Cell. Biol. 14:951–960.
   PubMedGoogle Scholar
• Watakabe, A., K. Tanaka, and Y. Shimura. 1993. The role of exon sequences in splice site selection. Genes Dev. 7:407–418.
   PubMed Web of Science ®Google Scholar
• Xu, R., J. Teng, and T. A. Cooper. 1993. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol. 13:3660–3674.
   PubMedGoogle Scholar
• Yeakley, J. M., F. Hedjran, J.-P. Morfin, N. Merillat, M. G. Rosenfeld, and R. B. Emeson. 1993. Control of calcitonin/calcitonin gene-related peptide pre-mRNA processing by constitutive intron and exon elements. Mol. Cell. Biol. 13:5999–6011.
   PubMedGoogle Scholar
• Zahler, A. M., W. S. Lane, J. A. Stolk, and M. B. Roth. 1992. SR proteins—a conserved family of pre-messenger-RNA splicing factors. Genes Dev. 6:837–847.
   PubMed Web of Science ®Google Scholar
• Zahler, A. M., K. M. Neugebauer, W. S. Lane, and M. B. Roth. 1993. Distinct functions of SR proteins in alternative pre-messenger RNA splicing. Science 260:219–222.
   PubMed Web of Science ®Google Scholar
• Zuker, M., and P. Steigler. 1981. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res. 9:133–148.
   PubMed Web of Science ®Google Scholar